ADVFN ADVFN

Hot Features

Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Dr Reddys Laboratories Ltd

Dr Reddys Laboratories Ltd (RDY)

13,19
-0,70
(-5,04%)
Fermé 13 Juillet 10:00PM
13,29
0,10
(0,76%)
Après les heures de négociation: 1:12AM

Dr Reddys Laboratories Ltd (RDY) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
13,29
( -4,32% )
Prix Achat
-
Prix Vente
-
Volume échangé
3 272 263
Volume moyen (3 m)
US$ 99 320
Volume financier
US$ 43 341 428
13,055 Fourchette du Jour 13,70
12,185 Plage de 52 semaines 15,67
Cap du marché
Valeur d'Entreprise
1,12T
Clôture Veille
13,89
Ouverture
13,61
Dernière Transaction
5
@
13.2819
Dernière heure de transaction
VWAP
13,2451
Chiffre d'affairess (LTM)
335,93B
Bénéfice net (LTM)
42,85B
Actions en circulation
832 691 395
Flottant (%)
72,02%
Détention Institutionnelle (%)
65,05%
Rendement du Dividende (LTM)
8 (0,63%)
Ratio Cours sur Bénéfices
26,33
Ratio Cours/Ventes (P/S)
3,36
Bénéfice par action (BPA)
51,42
Bêta
0,26

À propos de Dr Reddys Laboratories Ltd

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its G... Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. Its Others segment engages in developing therapies in the fields of oncology and inflammation; and research, development, and commercialization of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines, vitamins and minerals, and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India. Show more

Secteur
Health Care
Industrie
-
Site Web
Siège social
Hyderabad, India
Fondé
1984
Dr Reddys Laboratories Ltd est coté dans le secteur Health Care de la New York Stock Exchange avec le ticker RDY. Le dernier cours de clôture d'Dr Reddys Laboratories était de US$13,89. Au cours de la dernière année, les actions de Dr Reddys Laboratories ont été négociées dans une fourchette de prix de US$ 12,185 à US$ 15,67.

Dr Reddys Laboratories compte actuellement 832 691 395 actions en circulation. La capitalisation boursière d'Dr Reddys Laboratories est de US$11,07 milliard. Dr Reddys Laboratories a un ratio cours/bénéfice (ratio PE) de 26.33.

RDY Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.95-6.6713483146114.2414.7213.19338665314.15716643CS
4-0.07-0.52395209580813.3615.6713.08313741514.30491725CS
12-0.02-0.1502629601813.3115.6712.185268811513.6983365CS
26-0.18-1.3363028953213.4715.6712.185237815313.75090842CS
52-1.41-9.5918367346914.715.6712.185174222213.87055172CS
156-49.09-78.695094581662.3884.4612.185108416219.5466146CS
260-61.06-82.125084061974.3584.4612.18572477723.3844409CS

RDY - Frequently Asked Questions (FAQ)

What is the current Dr Reddys Laboratories Ltd share price?
The current share price of Dr Reddys Laboratories Ltd is US$ 13,29
How many Dr Reddys Laboratories Ltd shares are in issue?
Dr Reddys Laboratories Ltd has 832 691 395 shares in issue
What is the market cap of Dr Reddys Laboratories Ltd?
The market capitalisation of Dr Reddys Laboratories Ltd is USD 11,07B
What is the 1 year trading range for Dr Reddys Laboratories Ltd share price?
Dr Reddys Laboratories Ltd has traded in the range of US$ 12,185 to US$ 15,67 during the past year
What is the PE ratio of Dr Reddys Laboratories Ltd?
The price to earnings ratio of Dr Reddys Laboratories Ltd is 26,33
What is the cash to sales ratio of Dr Reddys Laboratories Ltd?
The cash to sales ratio of Dr Reddys Laboratories Ltd is 3,36
What is the registered address of Dr Reddys Laboratories Ltd?
The registered address for Dr Reddys Laboratories Ltd is 8-2-337, Road No. 3, Hyderabad, 500034
What is the Dr Reddys Laboratories Ltd website address?
The website address for Dr Reddys Laboratories Ltd is www.drreddys.com

RDY Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock